Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder
Abstract Introduction: Cannabis use disorder (CUD) is prevalent in ~2–5% of adults in the United States and is anticipated to…
Abstract Introduction: Cannabis use disorder (CUD) is prevalent in ~2–5% of adults in the United States and is anticipated to…
Abstract Cannabis use disorder (CUD) is a complex issue, even more so when it is comorbid with a severe mental…
Abstract Background: Cannabis is the most widely used illicit substance. Various countries have legalized cannabis for recreational use. Evidence on…
Abstract Background: Evidence for long-term effectiveness of commercial cannabis products used to treat medical symptoms is inconsistent, despite increasingly widespread…
Abstract Introduction: Increased legalization of cannabis use across the United States has been correlated with increased cannabis use in the…
Abstract Severe nausea and vomiting of pregnancy and hyperemesis gravidarum affect up to 3% of all pregnant people, causing substantial…
Abstract Cannabis use for medical and recreational purposes is increasing. Inhibitory activity of cannabinoids (CB) at the CB1 and CB2…
Abstract Rationale: Chronic cannabis use is associated with impaired cognitive function. Evidence indicates cannabidiol (CBD) might be beneficial for treating…
Abstract Introduction and aims: There is increasing interest and evidence for the use of cannabinoid medications in the treatment of…
Abstract Background: The use of cannabis has increased globally due to more regions decriminalizing marijuana use for therapeutic and recreational…